Nuveen Asset Management, LLC Mirati Therapeutics, Inc. Transaction History

Nuveen Asset Management, LLC

$345 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$41.99 - $62.38 $669,950 - $995,272	15,955 Added 5.73%	294,396 $17.3 Million
Q3 2023 Nov 14, 2023	BUY	$27.8 - $45.35 $1.29 Million - $2.11 Million	46,556 Added 20.08%	278,441 $12.1 Million
Q2 2023 Aug 14, 2023	SELL	$36.13 - $49.49 $1.03 Million - $1.41 Million	-28,524 Reduced 10.95%	231,885 $8.38 Million
Q1 2023 May 15, 2023	BUY	$36.54 - $54.26 $845,352 - $1.26 Million	23,135 Added 9.75%	260,409 $9.68 Million
Q4 2022 Feb 14, 2023	BUY	$41.27 - $98.62 $4 Million - $9.55 Million	96,877 Added 69.0%	237,274 $10.8 Million
Q3 2022 Nov 14, 2022	SELL	$59.5 - $86.7 $205,096 - $298,854	-3,447 Reduced 2.4%	140,397 $9.81 Million
Q2 2022 Aug 15, 2022	BUY	$39.16 - $88.71 $808,105 - $1.83 Million	20,636 Added 16.75%	143,844 $9.66 Million
Q1 2022 May 16, 2022	SELL	$75.82 - $150.97 $1.43 Million - $2.84 Million	-18,823 Reduced 13.25%	123,208 $10.2 Million
Q4 2021 Feb 14, 2022	SELL	$132.01 - $190.29 $2.05 Million - $2.95 Million	-15,499 Reduced 9.84%	142,031 $20.8 Million
Q3 2021 Nov 12, 2021	SELL	$132.13 - $177.45 $1.08 Million - $1.44 Million	-8,142 Reduced 4.91%	157,530 $27.9 Million
Q2 2021 Aug 16, 2021	SELL	$144.0 - $179.73 $7.08 Million - $8.84 Million	-49,169 Reduced 22.89%	165,672 $26.8 Million
Q1 2021 May 17, 2021	BUY	$158.92 - $221.61 $830,674 - $1.16 Million	5,227 Added 2.49%	214,841 $36.8 Million
Q4 2020 May 17, 2021	SELL	$162.05 - $240.27 $561,017 - $831,814	-3,462 Reduced 1.62%	209,614 $46 Million
Q4 2020 Feb 16, 2021	BUY	$162.05 - $240.27 $3.37 Million - $5 Million	20,813 Added 10.83%	213,076 $46.8 Million
Q3 2020 Nov 16, 2020	BUY	$113.26 - $167.27 $1.07 Million - $1.58 Million	9,457 Added 5.17%	192,263 $31.9 Million
Q2 2020 Aug 14, 2020	BUY	$72.01 - $120.39 $447,182 - $747,621	6,210 Added 3.52%	182,806 $20.9 Million
Q1 2020 May 14, 2020	BUY	$69.78 - $116.21 $3.73 Million - $6.21 Million	53,401 Added 43.35%	176,596 $13.6 Million
Q4 2019 Feb 14, 2020	SELL	$70.76 - $128.86 $63,684 - $115,974	-900 Reduced 0.73%	123,195 $15.9 Million
Q3 2019 Nov 14, 2019	BUY	$77.91 - $109.6 $1.11 Million - $1.56 Million	14,222 Added 12.94%	124,095 $9.67 Million
Q2 2019 Aug 15, 2019	BUY	$59.49 - $104.71 $6.54 Million - $11.5 Million	109,873 New	109,873 $11.3 Million

Others Institutions Holding MRTX

# of Institutions

Shares Held

3.57M

Call Options Held

Put Options Held

36.6K

View Full List

About Mirati Therapeutics, Inc.

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

More about MRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account